InvestSMART

Imugene Limited (ASX: IMU) - Announcements

Current share price for IMU : $0.036 0.001 (2.70%)+

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$20 Appendix 2A 3 Feb 2021 7:06PM $0.098 $0.036 fallen by 63.27%
$20 Proposed issue of Securities - IMU 3 Feb 2021 6:44PM $0.098 $0.036 fallen by 63.27%
$20 Appendix 4C - quarterly 29 Jan 2021 9:59AM $0.105 $0.036 fallen by 65.71%
$20 Appendix 2A 27 Jan 2021 7:12PM $0.110 $0.036 fallen by 67.27%
$20 Proposed issue of Securities - IMU 27 Jan 2021 6:50PM $0.110 $0.036 fallen by 67.27%
$20 Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial 21 Jan 2021 10:23AM $0.105 $0.036 fallen by 65.71%
$20 IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM 7 Jan 2021 9:43AM $0.100 $0.036 fallen by 64%
$20 Change of Director's Interest Notice - LC 23 Dec 2020 10:01AM $0.098 $0.036 fallen by 63.27%
$20 Change of Director's Interest Notice - PH 23 Dec 2020 9:18AM $0.096 $0.036 fallen by 62.50%
$20 Appendix 2A 22 Dec 2020 6:13PM $0.096 $0.036 fallen by 62.50%
$20 Proposed issue of Securities - IMU 22 Dec 2020 6:11PM $0.096 $0.036 fallen by 62.50%
$20 Change of Director's Interest Notice - AH 17 Dec 2020 4:34PM $0.099 $0.036 fallen by 63.64%
$20 Imugene Enrols First Cohort of PD1-Vaxx Clinical Trial 17 Dec 2020 9:04AM $0.099 $0.036 fallen by 63.64%
$20 Appendix 3G 16 Dec 2020 7:39PM $0.099 $0.036 fallen by 63.64%
$20 Appendix 2A 16 Dec 2020 7:38PM $0.099 $0.036 fallen by 63.64%
$20 Proposed issue of Securities - IMU 16 Dec 2020 7:37PM $0.099 $0.036 fallen by 63.64%
$20 Changes to Executive Chairman Remuneration 16 Dec 2020 12:36PM $0.105 $0.036 fallen by 65.71%
$20 Imugene Receives $4.82 million R&D Tax Incentive 10 Dec 2020 1:27PM $0.115 $0.036 fallen by 68.70%
$20 Appendix 2A and 708A Notice 9 Dec 2020 7:51PM $0.115 $0.036 fallen by 68.70%
$20 Proposed issue of Securities - IMU 9 Dec 2020 7:38PM $0.115 $0.036 fallen by 68.70%
$20 Change of Director's Interest Notice - CW 8 Dec 2020 2:01PM $0.128 $0.036 fallen by 71.76%
$20 Appendix 3G 3 Dec 2020 7:37PM $0.125 $0.036 fallen by 71.20%
$20 Appendix 2A 1 Dec 2020 8:11PM $0.130 $0.036 fallen by 72.31%
$20 Proposed issue of Securities - IMU 1 Dec 2020 7:46PM $0.130 $0.036 fallen by 72.31%
$20 Imugene First Patient Dosed in PD1-VAXX Clinical Trial 1 Dec 2020 8:33AM $0.120 $0.036 fallen by 70%

651 - 675 of 1205 results

Page 27 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.